Cytek Biosciences Proposes Terms For $248 Million IPO

LaylaBird/E+ via Getty Images
Quick Take
Cytek Biosciences (CTKB) has filed to raise $248 million in an IPO of its common stock, according to an S-1/A registration statement.
The firm provides cell analysis instruments to biomedical researchers and clinical…

Click here to view the original article.